Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in north-western India
Open Access
- 6 June 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 60 (2) , 312-316
- https://doi.org/10.1093/jac/dkm192
Abstract
We present antifungal susceptibility data on environmental isolates of Cryptococcus neoformans (serotype A, n = 117) and Cryptococcus gattii (serotype B, n = 65) cultured from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees. Susceptibilities to amphotericin B, fluconazole, ketoconazole, itraconazole and voriconazole were determined by using Etest. The MICs were read after 48 h as per the guidelines provided by the manufacturer. The MIC90s and susceptibility ranges for C. neoformans isolates were as follows: 0.094 (0.004–0.25) mg/L for amphotericin B, 4 (0.032–12) mg/L for fluconazole, 0.094 (0.004–0.75) mg/L for itraconazole, 0.064 (0.002–0.19) mg/L for ketoconazole, and 0.047 (0.006–0.125) mg/L for voriconazole, whereas for C. gattii isolates these were 0.125 (0.023–0.5) mg/L for amphotericin B, 8 (0.032–16) mg/L for fluconazole, 0.75 (0.006–2) mg/L for itraconazole, 0.125 (0.003–0.19) mg/L for ketoconazole, and 0.094 (0.004–0.125) mg/L for voriconazole. A comparison of the geometric means of MICs (mg/L) revealed that C. gattii was less susceptible than C. neoformans to amphotericin B (0.075 versus 0.051, P = 0.0003), fluconazole (2.912 versus 2.316, P = 0.003), itraconazole (0.198 versus 0.0344, P < 0.0001), ketoconazole (0.072 versus 0.037, P < 0.0001), and voriconazole (0.045 versus 0.023, P < 0.0001). The antifungal susceptibility data obtained in this study indicate that the occurrence of primary resistance among environmental isolates of C. neoformans serotype A and C. gattii serotype B is rare, and serotype B isolates are less susceptible than serotype A isolates.Keywords
This publication has 41 references indexed in Scilit:
- Do major species concepts support one, two or more species withinCryptococcus neoformans?FEMS Yeast Research, 2006
- Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002Journal of Antimicrobial Chemotherapy, 2004
- In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and CambodiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Fluconazole and itraconazole susceptibility ofclinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for careJournal of Antimicrobial Chemotherapy, 2003
- Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998Antimicrobial Agents and Chemotherapy, 2001
- Cryptococcus neoformansPublished by American Society for Microbiology ,1998
- The Hidden Danger of Primary Fluconazole Prophylaxis for Patients with AIDSClinical Infectious Diseases, 1998
- Possible Development of Resistance to Fluconazole During Suppressive Therapy for AIDS-Associated Cryptococcal MeningitisClinical Infectious Diseases, 1996
- Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passageAntimicrobial Agents and Chemotherapy, 1995
- Increased Fluconazole Resistance of Cryptococcus neoformans Isolated from a Patient with AIDS and Recurrent MeningitisClinical Infectious Diseases, 1994